What changed in this filing

/stocks — the workspaceLOADING

Item 5. Market for Registrant’s Common Equity

2024-03-27 compared with 2023-03-22 · 44 added, 13 removed, 24 unchanged (70% of the section changed)

MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

equity securities trade on the NYSE.

Each of our units consists of one Class A ordinary share and one-half of one redeemable warrant

and, commencing on November 19, 2021, trades on the NYSE under the symbol “IFIN.U.” The Class A ordinary shares and warrants

underlying our units began trading separately on the NYSE under the symbols “IFIN” and “IFIN.WS,” respectively,

on January 10, 2022.

of March 6, 2023 there were one holder of record of our units, one holder of record of our Class A ordinary shares, two holders

of record of our warrants and five holders of record of our Class B ordinary.

Such numbers do not include beneficial owners

holding our securities through nominee names.

units and Class A ordinary shares trade on the NYSE.

Each of our units consists of one Class A ordinary share and one-half of one

redeemable warrant and, commencing on November 19, 2021, trades on the NYSE under the symbol “IFIN.U.” The Class A

ordinary shares and warrants underlying our units began trading separately on the NYSE under the symbols “IFIN” and

“IFIN.WS,” respectively, on January 10, 2022.

Following the notice of delisting and suspension of trading of our

warrants by the NYSE due to “abnormally low” price levels, effective November 28, 2023, our warrants were delisted from

the NYSE effective December 13, 2023.

On January 19, 2024, we received the Notice from NYSE informing us that,

because the number of public shareholders is less than 300, we are not in compliance with Section 802.01B of the Listing Rule.

Rule requires us to maintain a minimum of 300 public stockholders on a continuous basis.

The Notice specifies that we have 45 days to

submit a business plan that demonstrates how we expect to return to compliance with the Listing Rule within 18 months of receipt of the

On March 4, 2024, we submitted such a business plan to demonstrate how we expect to return to compliance with the Listing Rule

within 18 months of receipt of the Notice.

The plan is currently under review by the sta f f

of NYSE Regulation.

If NYSE Regulation accepts the plan, we will be notified in writing and will be subject to periodic reviews includ i ng

quarterly monitoring for compliance with such plan.

If NYSE Regulation does not accept the plan, we will be subject to delisting procedures.

of March 21, 2024, there were one holder of record of our units, one holder of record of our Class A ordinary shares, two

holders of record of our warrants and five holders of record of our Class B ordinary shares.

Such numbers do not include beneficial

owners holding our securities through nominee names.

have not paid any cash dividends on our ordinary shares to date and do not intend to pay cash dividends prior to the completion of our

20 unchanged sentences

with Continental Stock Transfer & Company as trustee, established for the benefit of the Company’s public shareholders.

Transaction costs amounted to $9,351,106 consisting of $2,499,985 in cash of underwriting fees

and $6,851,121 of other offering costs.

The amount of funds available for a business combination is approximately $94.59 million after payment of $5,999,964 of deferred underwriting

fees and payment of an aggregate redemption amount of approximately $109.31 million as a result of the approval of the Extension Proposal.

costs amounted to $9,351,106 consisting of $2,499,985 in cash of underwriting fees and $6,851,121 of other offering costs.

February 14, 2023, the Company’s shareholders approved an amendment to the Charter to extend the date by which the Company

must consummate its initial business combination from February 23, 2023, upon additional funds being deposited into the

Company’s Trust Account to the First Extended Date.

In connection with the shareholder vote to approve the First Extension,

the holders of 10,415,452 Class A ordinary shares property exercised their right to redeem their shares for cash at a redemption

price of approximately $10.49 per share, for an aggregate redemption amount of approximately $109.31 million, leaving approximately

$100.59 million in the Trust Account.

August 18, 2023, the Company’s shareholders approved an amendment to the Charter to extend the date by which it has to consummate

a Business Combination from August 23, 2023 to the Second Extended Date.

In connection with

the votes to approve the Second Extension, the holders of 2,176,003 Class A ordinary shares of the Company properly exercised their right

to redeem their shares for cash at a redemption price of approximately $10.94 per share, for an aggregate redemption amount of approximately

$23.8 million, leaving approximately $81.1 million in the Company’s Trust Account.

February 16, 2024, the Company’s shareholders approved an amendment to the Charter to extend the date by which it has to consummate

a Business Combination from February 23, 2024 to the Third Extended Date.

In connection with

the votes to approve the Third Extension, the holders of 2,661,404 Class A ordinary shares of the Company properly exercised their right

to redeem their shares for cash at a redemption price of approximately $11.36 per share, for an aggregate redemption amount of approximately

$30.26 million, leaving approximately $53.97 million in the Company’s Trust Account.

a description of the use of the proceeds generated in our Initial Public Offering, see Part II, Item 7 of this Annual Report.

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 5. Market for Registrant’s Common Equity